140 related articles for article (PubMed ID: 11418003)
1. Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma.
Lo Muzio L; Staibano S; Pannone G; Mignogna MD; Mariggiò A; Salvatore G; Chieffi P; Tramontano D; De Rosa G; Altieri DC
Exp Mol Pathol; 2001 Jun; 70(3):249-54. PubMed ID: 11418003
[TBL] [Abstract][Full Text] [Related]
2. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
[TBL] [Abstract][Full Text] [Related]
3. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
4. Survivin as prognostic factor in squamous cell carcinoma of the oral cavity.
Lo Muzio L; Farina A; Rubini C; Pezzetti F; Stabellini G; Laino G; Santarelli A; Pannone G; Bufo P; de Lillo A; Carinci F
Cancer Lett; 2005 Jul; 225(1):27-33. PubMed ID: 15922854
[TBL] [Abstract][Full Text] [Related]
5. Increased survivin expression in high-grade oral squamous cell carcinoma: a study in Indian tobacco chewers.
Jane C; Nerurkar AV; Shirsat NV; Deshpande RB; Amrapurkar AD; Karjodkar FR
J Oral Pathol Med; 2006 Nov; 35(10):595-601. PubMed ID: 17032391
[TBL] [Abstract][Full Text] [Related]
6. Survivin expression in oral squamous cell carcinoma.
Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Rubini C; Mariggiò MA; Procaccini M; Ferrari F; De Rosa G; Altieri DC
Br J Cancer; 2003 Dec; 89(12):2244-8. PubMed ID: 14676801
[TBL] [Abstract][Full Text] [Related]
7. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis.
Zhou S; Qu X; Yu Z; Zhong L; Ruan M; Ma C; Wang M; Zhang C; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):575-81. PubMed ID: 20303055
[TBL] [Abstract][Full Text] [Related]
8. Survivin is a downstream target and effector of sulindac-sensitive oncogenic Stat3 signalling in head and neck cancer.
Scheper MA; Nikitakis NG; Sauk JJ
Int J Oral Maxillofac Surg; 2007 Jul; 36(7):632-9. PubMed ID: 17566705
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
10. Expression of the apoptosis inhibitor protein Survivin in primary laryngeal carcinoma and cervical lymph node metastasis.
Marioni G; Bertolin A; Giacomelli L; Marchese-Ragona R; Savastano M; Calgaro N; Marino F; De Filippis C; Staffieri A
Anticancer Res; 2006; 26(5B):3813-7. PubMed ID: 17094406
[TBL] [Abstract][Full Text] [Related]
11. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line.
Grossman D; McNiff JM; Li F; Altieri DC
Lab Invest; 1999 Sep; 79(9):1121-6. PubMed ID: 10496530
[TBL] [Abstract][Full Text] [Related]
12. High nuclear expression of the apoptosis inhibitor protein survivin is associated with disease recurrence and poor prognosis in laryngeal basaloid squamous cell carcinoma.
Marioni G; Ottaviano G; Marchese-Ragona R; Giacomelli L; Bertolin A; Zanon D; Marino F; Staffieri A
Acta Otolaryngol; 2006 Feb; 126(2):197-203. PubMed ID: 16428200
[TBL] [Abstract][Full Text] [Related]
13. Suppression of survivin expression by short hairpin RNA induces apoptosis in human laryngeal carcinoma cells.
Chen XM; Luan XY; Lei DP; Ma XJ; Liu XX; Liu J; Pan XL
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):168-75. PubMed ID: 18391576
[TBL] [Abstract][Full Text] [Related]
14. COX-independent antineoplastic effects of sulindac in oral cancer are mediated by survivin down-regulation.
Scheper MA; Sauk JJ; Nikitakis NG
Anticancer Res; 2006; 26(6B):4103-13. PubMed ID: 17201121
[TBL] [Abstract][Full Text] [Related]
15. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma.
Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP
Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972
[TBL] [Abstract][Full Text] [Related]
16. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
17. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
18. Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings.
Khan Z; Tiwari RP; Mulherkar R; Sah NK; Prasad GB; Shrivastava BR; Bisen PS
Head Neck; 2009 Aug; 31(8):1039-48. PubMed ID: 19340865
[TBL] [Abstract][Full Text] [Related]
19. Survivin expression in mouse skin prevents papilloma regression and promotes chemical-induced tumor progression.
Allen SM; Florell SR; Hanks AN; Alexander A; Diedrich MJ; Altieri DC; Grossman D
Cancer Res; 2003 Feb; 63(3):567-72. PubMed ID: 12566297
[TBL] [Abstract][Full Text] [Related]
20. Expression of survivin and XIAP for DMBA-induced hamster buccal pouch squamous cell carcinogenesis is associated with p53 accumulation.
Hsue SS; Chen YK; Lin LM
Oral Oncol; 2008 Jan; 44(1):43-9. PubMed ID: 17306609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
